ArticleFrontiers in digital health2025
Impact of tele-ultrasound on novice users in patients with suspected COVID-19 in an urgent care setting.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Point-of-care lung ultrasound (LUS) has been described for the evaluation of lung pathologies such as pneumothorax, pneumonia, and COVID-19 infections. It is rapidly deployed, portable, and accurate for LUS diagnoses. However, a learning curve limits its use, and teleguidance has been proposed as a solution. In this study, we primarily seek to measure the effect of tele-guided lung ultrasound (T-LUS) on chest X-ray (CXR) utilization in patients presenting with COVID-19 symptoms. Secondarily, we measure the effect of T-LUS on clinical decision-making, length of stay, and clinical outcomes. Results: We performed a retrospective observational study using a before-after design in an adult urgent care (AUC) setting. A total of 303 patients with symptoms suggestive of COVID-19 were included. AUC providers used T-LUS on 31% of patients with COVID-19 symptoms ( Conclusion: T-LUS is feasible and alters clinical decision-making for novice ultrasound users in the care of patients with suspected COVID-19 infection. Our results indicated that there was a no statistically significant difference trend in CXR utilization and no improvement in length of stay by the end of the 2-week trial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.